BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200115
DTEND;VALUE=DATE:20200117
DTSTAMP:20260515T042002
CREATED:20190802T125805Z
LAST-MODIFIED:20190802T125855Z
UID:21833-1579046400-1579219199@www.pharmajournalist.com
SUMMARY:Pre-Filled Syringes and Injectable Drug Devices 2020
DESCRIPTION:Assessing the regulatory environment and future of PFS design and development \nSMi are pleased to present the 12th Annual Pre-Filled Syringes and Injectable Drug Devices conference in London on 15th and 16th January 2020. \n \nAs Europe’s leading Pre-Filled Syringes conference\, the 2020 event will assess innovations in device engineering and components\, enhancement of human factors\, and optimizing packaging and containment. \nWith the rapid expansion of the PFS market\, the regulatory environment is more importance than ever. This year’s programme will look at the EU MDR\, Article 117 as well as insights into the MDR post-market surveillance requirements; providing a holistic review of the Pre-Filled Syringes industry. \nThis two-day agenda offers you peer-to-peer networking with Global Product Managers\, Senior Pre-Filled Syringes Engineers\, Device Testing Managers\, Heads of Late-Stage Pre-Filled Syringes Development\, Head of Medical Affairs\, Senior Director – Combination Products & Medical Devices\, Global Regulatory Affairs\, Quality Assurance Manager Combination Products \, Senior Pharmaceutical Assessor and many more. \nBENEFITS OF ATTENDING:  \n\nLearn about the technological innovations that are revolutionizing the injectable drug delivery space through novel device design\nDebate how can we prepare for the regulatory impact of Brexit and the EU MDR on devices\nHear industry experts uncovering the latest advancements optimizing drug biologics to improve PFS delivery\nAssess industry case studies exploring how to overcome challenges of extractables and leachables\n\nView the full agenda and speaker line-up online: www.pre-filled-syringes.com/pharmajwl \nPlus\, pre-conference workshop day will be taking place on 14th January in London: \nWorkshop A: A Roadmap to Regulation Quality Management Systems and Technical Standards \nWorkshop B: Testing Requirements of Pre-Filled Syringes led by Horst Koller\, CEO\, HK Packaging Consulting GmbH \nWorkshop C: Extractables and Leachables: Considerations for PFS Platforms \nEARLY-BIRD RATES:  \n\nBOOK BY 30TH SEPTEMBER AND SAVE £400\nBOOK BY 31ST OCTOBER AND SAVE £200\nBOOK BY 29TH NOVEMBER AND SAVE £100\n\nRegistrations can be made on the event website at: www.pre-filled-syringes.com/pharmajwl \nChairs for 2019: \n\nJames Mellman\, Device Manager\, Novartis\nAnil Busimi\, Strategy and Innovation Global Product Manager\, SCHOTT\n\nFeatured speakers: \n\nAbha Raveau-Violette\, Device Manager\, AstraZeneca\nAmanda Matthews\, Senior Director\, Pfizer\nAnil-Kumar Busimi\, Strategy and Innovation\, Senior Global Product Manager\, SCHOTT\nBenjamin Werner\, Scientist\, Boehringer Ingelheim Pharma GmbH & Co. KG\nCedric Gysel\, Healthcare Solutions Manager\, Johnson & Johnson\nCinzia Rotella\, Senior Materials Scientist\, Sanofi\nClemens Guenther\, Director Nonclinical Safety Consumer Care\, Bayer\nColin Roscoe\, Principal Human Factors Scientist\, Teva Pharmaceuticals\nHiroki Hasegawa\, Researcher\, Mitsubishi Gas Chemical Company\, Inc\nJames Mellman\, Device Manager\, Novartis A G\nKewei Yang\, Pharmaceutical Scientist\, Roche\nKhaudeja Bano\, Head of Medical Devices\, Abbott Molecular Inc\nMarion Westwood\, Pharmaceutical Assessor\, Medicines & Healthcare products Regulatory Agency (MHRA)\nMatthew Nicolas\, Investigator\, GlaxoSmithKline\nNicolas Eon\, Senior Global Product Manager\, SCHOTT\nOlaf Lebau\, Design Engineer for Medical Devices and Combination Products\, Boehringer Ingelheim GmbH\nRaphael Nudelman\, Director of Chemical and Computational Toxicology\, Teva Pharmaceuticals\nRemy Vomscheid\, Director\, Devices Development & Technologies\, IPSEN Pharmsciences\nTorsten Kneuss\, Quality Assurance Manager Combination Products\, Bayer Pharma\n\nContact Info: \nT: +44 (0)20 7827 6088\nE: hsidhu@smi-online.co.uk\nFollow us:  @SMiPharm #PFSSMi
URL:https://www.pharmajournalist.com/event/pre-filled-syringes-and-injectable-drug-devices-2020/
LOCATION:Copthorne Tara Hotel\, Kensington\, Scarsdale Pl\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group":MAILTO:hsidhu@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200120
DTEND;VALUE=DATE:20200122
DTSTAMP:20260515T042002
CREATED:20190823T095903Z
LAST-MODIFIED:20190823T095957Z
UID:22116-1579478400-1579651199@www.pharmajournalist.com
SUMMARY:Disruptive Technologies in Pharma
DESCRIPTION:The conference aims to bring together experts of emerging technologies to discover the opportunities with regards to Artificial intelligence\, Machine Learning\, Internet of Things\, Digital therapeutics\, eHealth and blockchain. The effect of these technologies on the industry will be discussed with the aim to highlight challenges related to the implementation of these new technologies and to discuss how to overcome them. \n \nIndustry case studies will reveal personal experiences and strategies to approaching digitalization\, providing a benchmark for practice and improving understanding of forecasts until 2020. \nTransformations require regulatory adjustments therefore\, the conference will also feature insights into new regulatory guidelines and standards of practice\, with special focus on the new class of drugs called digital therapeutics\, to provide a complete picture of every aspect of the transformation process. \nNetwork and learn from leading professionals such as Vice Presidents\, Directors Managers and Heads of: Emerging/Disruptive Technologies\, Artificial Intelligence\, Machine Learning\, Data Science/Analytics\, Technology\, External and Internal Innovation\, Digital IoT and Bioinformatics \nCHAIRS FOR 2020: \n\nKarl Hess\, Managing Director\, OnDigitalHealth Consulting\n\nFEATURED SPEAKERS INCLUDE: \n\nMark Campbell\, Freelance Regulatory Expert\, former NICE\nVladimir Anisimov\, Principal Data Scientist\, Amgen\nJoseph Dalton\, Global Lead Digital Health Solutions and Medical Outcomes\, Novartis\n\nFor more information and to register\, visit www.disruptivetech-pharma.com/pjwb \nContact Info: \nT: +44 (0) 20 7827 6164\nE: nhoward@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/disruptive-technologies-in-pharma/
LOCATION:HOLIDAY INN KENSINGTON FORUM\, 97 Cromwell Road\, London\, SW7 4DN\, United Kingdom
ORGANIZER;CN="SMi Group":MAILTO:nhoward@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200120
DTEND;VALUE=DATE:20200122
DTSTAMP:20260515T042002
CREATED:20190906T081615Z
LAST-MODIFIED:20190906T090018Z
UID:22273-1579478400-1579651199@www.pharmajournalist.com
SUMMARY:SMi’s 9th Annual Pharmaceutical Microbiology Conference
DESCRIPTION:SPONSORED BY\nAssociates of Cape Cod\, bioMérieux\, COPAN\, METTLER TOLEDO\, Microgenetics\, Reading Scientific Services Limited\, Veltek Associates \nCHAIRED BY\nJames Drinkwater\, Chairman\, Pharmaceutical and Healthcare Science Society\nOlivier Chancel\, Sterility and Aseptic Practices Expert\, Boehringer Ingelheim \nDiscovering optimised contamination control and the current regulatory landscape \nPharmaceutical Microbiology as an industry is projected to see significant advancements in the next five years. This forecast is largely attributed to rapid microbiology testing\, which has accounted for $3.5 billion last year\, while projected to reach nearly double at $6 billion by 2025\, and an estimated CAGR of 8.3% leading up to 2025. \nAt the very core of pharmaceutical microbiology is the accurate and reliable detection of microorganisms that would otherwise contaminate the pharmaceutical products manufactured. This demand for more rapid methods for detection and identification will be accompanied by equally important areas such as: contamination control strategies and environmental monitoring\, process automation\, and discussing updates to meet regulatory requirements. \nJoin us at SMi’s 9th Annual Pharmaceutical Microbiology Conference to explore novel and developing technologies that tackle the most pressing challenges and push innovation in world of pharmaceutical microbiology. \n Event Hashtag: #SMiPharmaMicroUK \nAt the 9th Annual Pharmaceutical Microbiology Conference\, you will gain insight into: \nFEATURED SPEAKERS INCLUDE: \n\n Luis Meirinhos-Soares\, GMP Inspector\,Infarmed IP\n Jim Polarine\, Senior Technical Service Manager\,STERIS Corporation\n Tim Eaton\, Sterile Manufacturing Specialist\,AstraZeneca\n Pratixa Patel\, Senior Director\,Microbiology and Stability Sciences\, GSK\n Ian Symonds\, Pharmaceutical Consultant\, SDA Pharma\n Michael Song\, Senior Manager\,MedImmune\n Maria Jose Zafra-Domene\, Microbiology QC Team Leader\,MeiraGTx\n Ingo Spreitzer\, Deputy Head Section Microbial Safety\,Paul Ehrlich Institute\n\n KEY HIGHLIGHTS INCLUDE FOR 2020 \n\nDiscuss the regulatory expectations and supportive guidance on bio-contamination control and monitoring in aseptic manufacturing of sterile products fromPHSS\nGain valuable insight from key opinion leaders in a panel discussion on the impact of the Annex 1revisions on pharmaceutical microbiology\nExamine the common myths and urban legends in the pharmaceutical industry related to contamination control from STERIS\nExplore container closure integrity and controls strategies ensuring product sterility from AstraZeneca\nRevisit the role of the Official Medicines Control Laboratories as the GMP back up from Infarmed IP\n\nView the full agenda: www.pharma-microbiology.com/PJwl \nWHO SHOULD ATTEND? \nSenior Microbiologist\, Lead Scientist\, Laboratory Manager\, QA Specialist Drug Substance External Manufacturer\, Business Development Manager – Testing\, Pharmaceutical Microbiology Consultant\, Higher Pharmacopoeia Scientist\, Analytical Standards Specialist \n EARLY BIRD-RATES \n\nBOOK BY 30TH SEPTEMBER AND SAVE £400\nBOOK BY 31ST OCTOBER AND SAVE £200\nBOOK BY 29TH NOVEMBER AND SAVE £100
URL:https://www.pharmajournalist.com/event/smis-9th-annual-pharmaceutical-microbiology-conference/
LOCATION:Copthorne Tara Hotel\, London\, UK\, United Kingdom
ORGANIZER;CN="SMi Group":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200127
DTEND;VALUE=DATE:20200131
DTSTAMP:20260515T042002
CREATED:20191002T103300Z
LAST-MODIFIED:20191002T104019Z
UID:22677-1580083200-1580428799@www.pharmajournalist.com
SUMMARY:Temperature Control and Logistics
DESCRIPTION:The Temperature Control and Logistics forum remains the industries foremost operational and hands on conference to discuss everything logistics\, supply chain and temperature controlled for the Pharmaceutical Industry. \n \nOur vision for 2020 is to ensure that we remain true to our role in the industry – building a network of world leading expert speakers and facilitators alongside the industries leading solution providers and attendees to address how we can work together to practically advance the industry past the biggest and current hurdles and challenges. We are committed to ensuring that we help every single delegate\, industry partner and expert speaker to achieve their unifying goal: Transforming the industries current capabilities by optimising global logistics and supply chain processes to better serve the patient populations at the heart of the conversation. \nAcross four days of workshops\, keynote presentations\, case studies\, interactive think tank discussions and networking – we will ensure that the industry leaves with the strategies\, solutions and partners to overcome their most pressing operational challenges in order to make industry transformation and – patient care – possible. \nTo learn more about Temperature Control and Logistics visit http://bit.ly/2mRcY8I
URL:https://www.pharmajournalist.com/event/temperature-control-and-logistics/
LOCATION:Crowne Plaza Dusseldorf – Neuss\, Dusseldorf
ORGANIZER;CN="IQPC":MAILTO:enquire@iqpc.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200128
DTEND;VALUE=DATE:20200131
DTSTAMP:20260515T042002
CREATED:20191020T175731Z
LAST-MODIFIED:20191020T175731Z
UID:22984-1580169600-1580428799@www.pharmajournalist.com
SUMMARY:Commercializing Continuous Processing in Pharma (CCP)
DESCRIPTION:The CCP Summit 2020 is the only dedicated community for continuous manufacturing commercialization in Pharma. \nFour years in the drug development world isn’t long\, and the progress made in continuous processing has been an extraordinary. Thanks to the encouragement of the FDA and maturing technology; both pharma and biotech are starting to adopt continuous manufacturing (CM) in a commercial setting. \nOver the last 12 months we have seen major milestones in continuous manufacturing globally – PROSPECT project in the UK\, GSK’s announcement of CM facilities in Singapore\, Merck has filed an NDA under CM approach\, Bill & Melinda Gates Foundation granted $14.3m to Univercells to deploy CM for measles and rubella vaccine continuous manufacturing. \nAt the 4th Annual CCP Summit we will continue to explore scientific and technology advancements that can help eliminate bottlenecks\, and more importantly\, will address the quality\, upfront investment and business rationale behind the ‘switch’. \nThis is the one and only CCP meeting bringing together small molecules and biologics experts under one roof for knowledge and experience exchange! \nJoin us in Boston for the 4th time on Jan 28 – 30\, 2020.  Find out more about the CCP Summit > https://ter.li/9slw1t
URL:https://www.pharmajournalist.com/event/commercializing-continuous-processing-in-pharma-ccp/
LOCATION:The Colonnade\, 120 Huntington Avenue\, Boston\, MA\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR